Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2008, 54, 134-140

https://doi.org/10.14712/fb2008054040134

Determination of Angiogenic Factors in Serum by Protein Array in Patients with Renal Cell Carcinoma

Š. Lukešová1,2, Otakar Kopecký1,2, V. Vroblová3, D. Hlávková3, C. Andrýs3, P. Morávek4, E. Čermáková5

1Charles University in Prague, Faculty of Medicine and University Teaching Hospital in Hradec Králové, Second Department of Internal Medicine, Hradec Králové, Czech Republic
2District Hospital in Náchod, Department of Oncology, Náchod, Czech Republic
3Charles University in Prague, Faculty of Medicine and University Teaching Hospital in Hradec Králové, Institute of Clinical Immunology and Allergology, Hradec Králové, Czech Republic
4Charles University in Prague, Faculty of Medicine and University Teaching Hospital in Hradec Králové, Department of Urology, Hradec Králové, Czech Republic
5Charles University in Prague, Faculty of Medicine and University Teaching Hospital in Hradec Králové, Computer Technology Center, Hradec Králové, Czech Republic

Received February 15, 2008
Accepted August 13, 2008

References

1. Beecken, W. D., Bentas, W., Glienke, W., Linneweber, J., Jonas, D., Binder, J., Kramer, W., (2002) Serum angiogenic activity: diagnostic relevance in renal cell carcinoma. Eur. Urol. 42, 364-369. <https://doi.org/10.1016/S0302-2838(02)00359-7>
2. Cook, E. B., Stahl, J. L., Lowe, L., Chen, R., Morgan, E., Wilson, J., Varro, R., Chan, A., Graziano, F. M., Barney, N. P. (2001) Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J. Immunol. Methods. 254, 109–118. <https://doi.org/10.1016/S0022-1759(01)00407-0>
3. Copeland, S., Siddiquiq, J., Remick, D. (2004) Direct comparison of traditional ELISAs and membrane protein arrays for detection and quantification of human cytokines. J. Immunol. Methods 284, 99-106. <https://doi.org/10.1016/j.jim.2003.10.011>
4. Coussens, L. M., Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867. <https://doi.org/10.1038/nature01322>
5. Demayo, F., Minoo, P., Plopper, C. G., Schuger, L., Shannon, J., Torday. J. S. (2002) Mesenchymal-epithelial interactions in lung development and repair: are modeling and remodeling the same process? Am. J. Physiol. Lung Cell Mol. Physiol. 283, L510–L517. <https://doi.org/10.1152/ajplung.00144.2002>
6. Distler, J. H., Hirth, A., Kurowska-Stolarska, M., Gay, R. E., Gay, S., Distler, O. (2003) Angiogenic and angiostatic factor in the molecular control of angiogenesis. Q. J. Nucl. Med. 47, 149-161.
7. Edgren, M., Lennermas, B., Larson, A., Kälkner, K. M. (2001) Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma. Anticancer Res. 21, 1423-1429.
8. Eppenberger, U., Kueng, W., Schlaeppi, J. M., Roesel, J. L., Benz, C., Mueller, H., Matter, A., Zuber, M., Luescher, K., Litschgi, M., Schmitt, M., Foekens J. A., Eppenberger-Castori, S. (1998) Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J. Clin. Oncol. 16, 3129-3136. <https://doi.org/10.1200/JCO.1998.16.9.3129>
9. Glasson, M. J., Molloy, M. P, Walsh, B. J., Willcox, M. D., Morfia, C. A., Williams, K. L. (1998) Development of mini-gel technology in two-dimensional electrophoresis for mass-screening of samples: application to tears. Electrophoresis 9, 852-855. <https://doi.org/10.1002/elps.1150190541>
10. Greene, F. L., Page, D., Morow, M., et al. (2002) AJCC Cancer Staging Manual. 6th ed. Springer, New York.
11. Heldin, C. H., Westermark, B., Wasteson, A. (1979) Platelet-derived growth factor: purification and partial characterization. Proc. Natl. Acad. Sci. USA 76, 3722-3726. <https://doi.org/10.1073/pnas.76.8.3722>
12. Hemmerlein, B., Johanns, U., Kugler, A., Reffelmann M., Radzun, H. J. (2001) Quantification and in situ localization of MCP-1 mRNA and its relation to the immune response of renal cell carcinoma. Cytokine 13, 227-233. <https://doi.org/10.1006/cyto.2000.0823>
13. Herber, S., Grus, F. H., Sabuncuo, P., Augustin, A. J. (2001) Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis 22, 1838-1844. <https://doi.org/10.1002/1522-2683(200105)22:9<1838::AID-ELPS1838>3.0.CO;2-7>
14. Huang, R. P., Huang, R., Fan, Y., Lin, Y. (2001) Simultaneous detection of multiple cytokines from conditioned media and patient’s sera by an antibody-based protein array system. Anal. Biochem. 294, 55-62. <https://doi.org/10.1006/abio.2001.5156>
15. Hu, G. F., Riordan, J. F., Vallee, B. L. (1997) A putative angiogenin receptor in angiogenin-responsive human endothelial cells. Proc. Natl. Acad. Sci. USA 94, 2204-2209. <https://doi.org/10.1073/pnas.94.6.2204>
16. Kulbe, H., Hagemann, T., Szlosarek, P. W., Balkwill, F. R., Wilson J. R. (2005) The inflammatory cytokine tumor necrosis factor-α regulates chemokine receptor expression on ovarian cancer cells. Cancer Res. 65, 10355-10362. <https://doi.org/10.1158/0008-5472.CAN-05-0957>
17. Lewis, C. E., Pollard, J. W. (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66, 605-612. <https://doi.org/10.1158/0008-5472.CAN-05-4005>
18. Li, M., Jendrossek, V., Belka, C. (2007) The role of PDGF in radiation oncology. Radiat. Oncol. 2, 5. <https://doi.org/10.1186/1748-717X-2-5>
19. Lindroos, P. M., Coin, P. G., Badgett, A., Morgan, D. L., Bonner, J. C. (1997) Alveolar macrophages stimulated with titanium dioxide, chrysotile asbestos, and residual oil fly ash upregulate the PDGF receptor-α on lung fibroblasts through an IL-1β-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 16, 283-292. <https://doi.org/10.1165/ajrcmb.16.3.9070613>
20. Negus, R. P. M., Turner, L., Burke, F., Balkwill, F. R. (1998) Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors. J. Leukoc. Biol. 63, 758-765. <https://doi.org/10.1002/jlb.63.6.758>
21. O’Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328. <https://doi.org/10.1016/0092-8674(94)90200-3>
22. Ostman, A., Heldin, C. H. (2001) Involvement of plateled-derived growth factor in disease: development of specific antagonists. Adv. Cancer Res. 80, 1-38. <https://doi.org/10.1016/S0065-230X(01)80010-5>
23. Pavel, M. E., Hassler, G., Baum, U., Hahn, E. G., Lohmann, T., Schuppan, D. (2005) Circulating levels of angiogenic cytokines can predict tumour progression and prognosis in neuroendocrine carcinomas. Clin. Endocrinol. 62, 434-443. <https://doi.org/10.1111/j.1365-2265.2005.02238.x>
24. Sack, R. A., Conradi, L., Krumholz, D., Beaton, A., Sathe, S., Morris, C. (2005) Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents. Invest. Ophthalmol. Vis. Sci. 46, 1228-1238. <https://doi.org/10.1167/iovs.04-0760>
25. Sheen-Chen, S. M., Eng, H. L., Chen, W. J., Chou F. F., Chen, H. S. (2000) Serum level of angiogenin in breast cancer. Anticancer Res. 20, 4769-4771.
26. Sica, A., Schioppa, T., Mantovani, A., Allavena, P. (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717-727. <https://doi.org/10.1016/j.ejca.2006.01.003>
27. Sido, B., Teklote, J. R., Hartel, M., Friess, H., Büchler, M. W. (2004) Inflammatory response after abdominal surgery. Best Pract. Res. Clin. Anaesthesiol. 18, 439-459. <https://doi.org/10.1016/j.bpa.2003.12.006>
28. Stadler, W. M. (2005) Targeted agents for the treatment of advanced renal cell carcinoma. Cancer 104, 2323-2333. <https://doi.org/10.1002/cncr.21453>
29. Sulzbacher, I., Birner, P., Träxler, M., Marberger, M., Haitel, A. (2003) Expression of plateled-derived growth factor-α α receptor is associated with tumor progression in clear cell renal cell carcinoma. Am. J. Clin. Pathol. 120, 107-112. <https://doi.org/10.1309/LQ9EMK8QKE75NGGX>
30. Tawfik, O. W., Kramer, B., Shideler, B., Danley, M., Kimler, B. F., Holzbeierlein, J. (2007) Prognostic significance of CD44, plateled-derived growth factor receptor α, and cyclooxygenase 2 expression in renal cell carcinoma. Arch. Pathol. Lab. Med. 131, 261-267. <https://doi.org/10.5858/2007-131-261-PSOCPG>
31. Ueno, T., Toi, M., Saji, H., Muta, M., Bando, H., Kuroi, K., Koike, M., Inadera, H., Matsushima, K. (2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human brest cancer. Clin. Cancer Res. 6, 3282-3289.
32. Wechsel, H. W., Bichler, K. H., Feil, G., Loeser, W., Lahme, S., Petri, E. (1999) Renal cell carcinoma: relevance of angiogenetic factors. Anticancer Res. 19, 1537-1540.
33. Wetzler, C., Kämpfer, H., Stallmeyer, B., Pfeilschifter, J., Frank, S. (2000) Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: Prolonged persistence of neutrophils and macrophages during the late phase of repair. J. Invest. Dermatol. 115, 245-253. <https://doi.org/10.1046/j.1523-1747.2000.00029.x>
34. Xu, L., Tong, R., Cochran, D. M., Jain, R. K. (2006) Blocking plateled-derived growth factor-D/plateled-derived growth factor receptor β signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model. Cancer Res. 65, 5711-5719. <https://doi.org/10.1158/0008-5472.CAN-04-4313>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive